Global GMP Grade High Salt-Active Nuclease (SAN) Market Strategic Research Report

Scope of the Report

The global GMP Grade High Salt-Active Nuclease (SAN) market size is predicted to grow from US$ 16.50 million in 2025 to US$ 90.27 million in 2032; it is expected to grow at a CAGR of 24.7% from 2026 to 2032.

In 2025, globalGMP Grade High Salt-Active Nuclease (SAN) production reached approximately 16.9 K MU, with an average global market price of around 998 USD per MU.

GMP Grade High Salt-Active Nuclease (SAN) refers to a GMP-grade, recombinant, non-specific endonuclease that is designed to efficiently degrade residual nucleic acids, including single-stranded and double-stranded DNA and RNA, under high-salt bioprocessing conditions. Unlike conventional nucleases that may show reduced activity in elevated salt environments, high salt-active SAN maintains strong enzymatic activity in salt-containing process streams and is mainly used for host-cell nucleic acid removal, lysate viscosity reduction, chromatin degradation and downstream purification support in viral vector, vaccine, recombinant protein and other biologics manufacturing.

The core value of GMP Grade High Salt-Active Nuclease (SAN) lies in its ability to maintain strong nucleic acid degradation performance under medium- to high-salt bioprocessing conditions, addressing the limitation of conventional nucleases whose activity may decline in high-salt environments. In the manufacturing of AAV, lentiviral vectors, adenoviral vectors, vaccines and recombinant proteins, residual host-cell DNA/RNA, high lysate viscosity and heavy downstream purification burden remain major process challenges. By directly degrading residual nucleic acids in salt-containing process streams, SAN can reduce the need for additional desalting, buffer exchange or process redesign, helping manufacturers improve purification efficiency, simplify workflows and strengthen consistency in GMP production.

As cell and gene therapy, viral vector manufacturing, vaccines and next-generation biologics move further toward scale-up, regulatory compliance and commercial production, demand is increasing for GMP-grade process enzymes with robust quality systems, batch-to-batch consistency, regulatory documentation and broad process compatibility. Compared with research-grade nucleases, GMP Grade SAN is not merely an enzyme reagent, but a critical biomanufacturing tool that supports process efficiency, impurity control and regulatory readiness. Looking ahead, as high-salt purification strategies become more widely adopted in AAV and related biologics workflows, and as CDMOs and biopharma companies place greater emphasis on residual nucleic acid control, GMP Grade Salt-Active Nuclease is well positioned to become an important enabling material in advanced biomanufacturing.

The upstream raw materials for GMP Grade High Salt-Active Nuclease (SAN) mainly include recombinant expression systems, microbial fermentation media, GMP-grade buffer salts and stabilizers, chromatography packing materials, filtration/ultrafiltration consumables, quality control reagents, and pharmaceutical packaging materials. Representative suppliers include Thermo Fisher Scientific, Merck KGaA/MilliporeSigma, Avantor, Cytiva, Sartorius, Repligen, Kerry, BD Difco, Organotechnie/Solabia, SCHOTT Pharma, Stevanato Group, and West Pharmaceutical. Downstream applications are primarily in recombinant proteins, viral vaccines, and viral vectors. Typical customers include Thermo Fisher, Lonza, Oxford Biomedica, Sanofi, GSK, Merck, Pfizer, AstraZeneca, SK Bioscience, Sinopharm Group, and Sinovac Biotech, among others.

GMP Grade High Salt-Active Nuclease (SAN) varies greatly depending on product type, process path, and degree of automation, with industry gross margins typically ranging from 70% to 80%.

Global key GMP Grade High Salt-Active Nuclease (SAN) players cover ArcticZymes Technologies, New England Biolabs, QIAGEN N.V., Merck KGaA, c-LEcta GmbH, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global GMP Grade High Salt-Active Nuclease (SAN) market?

What factors are driving GMP Grade High Salt-Active Nuclease (SAN) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do GMP Grade High Salt-Active Nuclease (SAN) market opportunities vary by end market size?

How does GMP Grade High Salt-Active Nuclease (SAN) break out by Target Impurity, by Application?

This report presents a comprehensive overview of the global GMP Grade High Salt-Active Nuclease (SAN) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Target Impurity

• Host DNA Clearance Nuclease
• Host RNA Clearance Nuclease
• Others

Segment by Form

• Liquid
• Lyophilized Powder

Segment by Application

• Recombinant Protein
• Viral Vaccine
• Viral Vector
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global GMP Grade High Salt-Active Nuclease (SAN) market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Recombinant Protein, Viral Vaccine, Viral Vector evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact